Alanylglutamine

Preferred Label : Alanylglutamine;

NCIt synonyms : L-alanyl/L-glutamine; L-alanyl-L-glutamine; Alanyl-glutamine; Ala-Gln; AG; N(2)-L-Alanyl-L-glutamine;

NCIt related terms : ALANYL GLUTAMINE;

NCIt definition : A nutritional supplement containing a stable, water-soluble dipeptide comprised of the amino acids L-glutamine and L-alanine, with potential protective and absorption enhancing activities. Upon oral or enteral administration, alanylglutamine works locally in the gastrointestinal (GI) tract to both protect the integrity of the intestinal mucosa and maintain intestinal barrier functions. This reduces bacterial translocation, the risk of infection, infection-induced inflammatory damage and infection-associated symptoms, such as diarrhea, dehydration, malabsorption and electrolyte imbalances. Alanylglutamine also increases absorption of other chemicals, enhances epithelial repair, and inhibits apoptosis due to cellular damage, and stimulates cellular proliferation. Altogether, this improves absorption of nutrients, decreases weight loss, reduces diarrhea, decreases the risk of GI-associated infections and improves recovery. Upon absorption, alanylglutamine may also help inhibit muscle protein catabolism.;

UNII : U5JDO2770Z;

InChIKey : HJCMDXDYPOUFDY-WHFBIAKZSA-N;

CAS number : 39537-23-0; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 39537-23-0 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Drug name : Sustamine;

Details

Origin ID

C127908;

UMLS CUI

C0051080;

Automatic exact mappings (from CISMeF team)
- Angular gyrus [FMA entity]
- Anion gap [LOINC component]
- acid-base equilibrium [MeSH Descriptor]
- anesthesia, general [MeSH Descriptor]
- arthrogryposis [MeSH Descriptor]
- fatty acids [MeSH Descriptor]
Currated CISMeF NLP mapping
- Alanylglutamine (substance) [SNOMED CT concept]
- N(2)-L-alanyl-L-glutamin [Artificial nutrition thesaurus concept]
- alanylglutamine [MeSH concept]
- alanylglutamine [MeSH Supplementary Concept]
False automatic mappings
- A Ag [LOINC component]
- Age [LOINC component]
- Age (qualifier value) [SNOMED CT concept]
- Aging [OMIM Phenotype]
- Aging (finding) [SNOMED CT concept]
- Aicardi-goutieres syndrome 1 [OMIM Phenotype]
- Atrophic gastritis (disorder) [SNOMED CT concept]
- Chronic atrophic gastritis of unknown aetiology [ICD-11 Sub-sub category]
- Current chronological age (observable entity) [SNOMED CT concept]
- age [OBI concept]
- age [ICPS Descriptor]
- aged [MeSH concept]
- aged [MeSH Descriptor]
- aging [MeSH concept]
- aging [MeSH Descriptor]
- aging [GO term]
- aging [CISMeF Querying Strategy]
- jagged canonical Notch ligand 1 [ORDO Gene]
See also inter- (CISMeF)
- Product containing alanylglutamine (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Biologically Active Substance [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Alanylglutamine (substance) [SNOMED CT concept]
- Product containing alanylglutamine (medicinal product) [SNOMED CT concept]
- alanyl glutamine [ATC Code]
- alanylglutamine [MeSH Supplementary Concept]
- alanylglutamine [MeSH concept]
Validated automatic mappings to BTNT
- alanyl glutamine [ATC Code]
concept_is_in_subset
- CTRP Agent Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients